Ticker Details
Biofrontera Inc.
IPO Date:	October 29, 2021
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$10.34M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.12 | 5.16%
Avg Daily Range (30 D):	$0.03 | 3.45%
Avg Daily Range (90 D):	$0.04 | 3.83%

Institutional Daily Volume
Avg Daily Volume:	1.48M
Avg Daily Volume (30 D):	.21M
Avg Daily Volume (90 D):	.32M

Trade Size
Avg Trade Size (Sh.):	276
Avg Trade Size (Sh.) (30 D):	361
Avg Trade Size (Sh.) (90 D):	357

Institutional Trades
Total Institutional Trades:	27
Avg Institutional Trade:	$1.17M
Avg Institutional Trade (30 D):	$2.12M
Avg Institutional Trade (90 D):	$2.12M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$.74M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	4.51K

News

May 8, 2026 @ 8:00 PM Biofrontera Inc. to Report First Quarter 2026 Fina... Source: Na

Dec 4, 2025 @ 2:00 PM Last Patient Completes Biofrontera’s Phase ... Source: Biofrontera Inc.

Aug 14, 2025 @ 7:01 PM Biofrontera Q2 Revenue Jumps 15% Source: Hermann Luebbert

Aug 13, 2025 @ 9:20 PM Biofrontera Inc. Reports Second Quarter 2025 Finan... Source: Hermann Luebbert

Aug 4, 2025 @ 6:00 PM Biofrontera Inc. to Report Second Quarter FY 2025 ... Source: Andrew Barwicki

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.98	$-.41	$.63
Diluted EPS	$-.98	$-.41	$.63
Revenue	$43.2M	$10.08M	$17.1M
Gross Profit
Net Income / Loss	$-11.09M	$-4.75M	$5.64M
Operating Income / Loss	$-11.12M	$-4.32M	$4.56M
Cost of Revenue
Net Cash Flow	$.49M	$M	$2.98M
PE Ratio

Splits
Jul 05, 2023	1:20